Literature DB >> 4955538

Waldenström's macroglobulinaemia treated with cylophosphamide and chlorambucil.

R M Buckle, G C Jenkins, G L Mills.   

Abstract

A case of primary macroglobulinaemia of Waldenström is described in which prolonged treatment with the alkylating agents of cyclophosphamide and chlorambucil led to a sustained reduction in the concentration of circulating macroglobulin together with a concurrent improvement in the patient's symptoms.

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4955538      PMCID： PMC473159          DOI： 10.1136/jcp.19.1.55

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  19 in total

1.  Continuous chlorambucil therapy in primary macroglobulinemia of Waldenstrom: report of four cases.

Authors:  E D BAYRD
Journal:  Proc Staff Meet Mayo Clin       Date:  1961-03-15

2.  Macroglobulins and macroglobulinaemia.

Authors:  I R MACKAY
Journal:  Australas Ann Med       Date:  1959-05

3.  Effect of prednisolone on anaemia associated with macroglobulinemia.

Authors:  W R PITNEY; W J O'SULLIVAN; J A OWEN
Journal:  Br Med J       Date:  1958-12-20

4.  Neurologic aspects of Waldenstrom's macroglobulinemia; report of a case.

Authors:  J LOGOTHETIS; P SILVERSTEIN; J COE
Journal:  Arch Neurol       Date:  1960-11

5.  The effect of some mercaptanes upon a macrocryogelglobulin; modifications induced by cysteamine, penicillamine and penicillin.

Authors:  S E RITZMANN; S L COLEMAN; W C LEVIN
Journal:  J Clin Invest       Date:  1960-08       Impact factor: 14.808

6.  The syndrome of macroglobulinemia. Review of the literature and a report of two cases of macrocryogelglobulinemia.

Authors:  S E RITZMANN; R H THURM; W E TRUAX; W C LEVIN
Journal:  Arch Intern Med       Date:  1960-06

7.  Macroglobulinemia: report of two cases.

Authors:  H GLENCHUR; H H ZINNEMAN; D R BRIGGS
Journal:  Ann Intern Med       Date:  1958-05       Impact factor: 25.391

8.  Human serum macroglobulins and dissociation units. I. Physicochemical properties.

Authors:  H F DEUTSCH; J I MORTON
Journal:  J Biol Chem       Date:  1958-04       Impact factor: 5.157

9.  [Pathological anatomy of Waldenstrom's macroglobulinemia].

Authors:  H U ZOLLINGER
Journal:  Helv Med Acta       Date:  1958-05

10.  [Clinical manifestations of Waldenstrom's macroglobulinemia; report of 21 cases & review of the literature].

Authors:  R KAPPELER; A KREBS; G RIVA
Journal:  Helv Med Acta       Date:  1958-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.